Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy.
about
Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo.A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor.Deprivation of asparagine triggers cytoprotective autophagy in laryngeal squamous cell carcinoma.Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo.Role of glutamine and interlinked asparagine metabolism in vessel formation.
P2860
Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy.
@en
type
label
Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy.
@en
prefLabel
Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy.
@en
P2093
P2860
P1476
Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy.
@en
P2093
Boyang Zhang
Dianwen Ju
Jiajun Fan
Weitao Shen
Xuyao Zhang
Zhonglian Cao
Zhongyuan Xu
P2860
P2888
P304
P356
10.1007/S00253-016-7640-3
P407
P577
2016-06-01T00:00:00Z
P6179
1004654966